EYET

Eyetech (EYET)

Eyetech Pharmaceuticals (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EYET

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2005/11/13	07:52	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Confirm November 14th Closing	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/11/11	01:30	PR Newswire (US)	Eyetech Provides Update on Status of Pending Acquisition by OSI Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/11/01	07:00	PR Newswire (US)	Eyetech Reports Third Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/10/17	22:30	PR Newswire (US)	Eyetech Announces Enrollment of the First Patient in a Phase 3 Clinical Trial of Macugen(R) (pegaptanib sodium injection) in Dia	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/10/05	22:30	PR Newswire (US)	Recent Analyses Suggest That Treatment With Macugen(R) (pegaptanib sodium injection) May Provide Better Results for Patients Wit	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/09/16	22:15	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Receives Positive Opinion for Treatment of Neovascular Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/08/22	09:48	PR Newswire (US)	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement	NASDAQ:EYET
2005/08/22	08:45	Business Wire	OSI Pharmaceuticals and Eyetech Pharmaceuticals Announce Signing of Definitive Merger Agreement; Acquisition Projected to be Acc	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/08/09	22:30	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Named Innovative Pharmaceutical Product Of The Year At The 2005 Pharmaceutical Achievem	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/07/28	06:30	PR Newswire (US)	Eyetech Reports Second Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/07/19	03:30	PR Newswire (US)	Eyetech and Pfizer Comment on Data Presented at Meeting of Retinal Specialists	NASDAQ:EYET
2005/07/16	02:30	PR Newswire (US)	Eyetech To Announce Second Quarter 2005 Financial Results On July 27, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/22	21:30	PR Newswire (US)	Eyetech Raises Full-Year Sales Forecast for Macugen(R) (pegaptanib sodium injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/22	04:33	PR Newswire (US)	Eyetech Vision Day to Preview Future of Macugen Franchise	NASDAQ:EYET
2005/06/14	08:34	PR Newswire (US)	Eyetech to Host Vision Day on Wednesday, June 22	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/11	06:29	Business Wire	Schaeffer's Midday Options Update Features General Motors, Citigroup, Northrop Grumman, Intel, and Eyetech Pharmaceuticals	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/10	21:31	PR Newswire (US)	Eyetech Announces Appointment of Henry Simon as Chairman of the Board and Resignation of John McLaughlin	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/06/09	21:30	PR Newswire (US)	Eyetech Adopts Stockholder Rights Agreement	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/25	10:30	PR Newswire (US)	Eyetech Announces Conference Call to Reiterate Confidence in Macugen(R) (Pegaptanib Sodium Injection)	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/24	21:30	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Brazil for the Treatment of Neovascular (Wet) Age-Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/11	07:30	PR Newswire (US)	Eyetech to Present at the 2005 UBS Global Pharmaceuticals Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/06	06:10	PR Newswire (US)	Eyetech Announces Approval of Macugen(R) in Canada for The Treatment of Neovascular (Wet) Age Related Macular Degeneration	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/05	23:19	PR Newswire (US)	Macugen(R) (pegaptanib sodium injection) Studied in Treatment of Diabetic Macular Edema (DME) and Other Diabetic Retinopathy Les	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/03	06:10	PR Newswire (US)	Preclinical Study Demonstrates Significance of VEGF164 in Pathological Neovascularization	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/05/03	06:10	PR Newswire (US)	Safety Profile of Macugen(R) (pegaptanib sodium injection) in the Treatment of Neovascular Age-Related Macular Degeneration (AMD	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/22	06:30	PR Newswire (US)	Eyetech to Present at Morgan Stanley's Third Annual Global Healthcare Unplugged Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/21	07:09	PR Newswire (US)	Eyetech Reports First Quarter 2005 Financial Results	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/08	06:30	PR Newswire (US)	Eyetech Announces Co-Founder Marty Glick Steps Down From Board To Act As Consultant	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/04/08	06:30	PR Newswire (US)	Eyetech to Announce First Quarter 2005 Financial Results on April 20, 2005	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)
2005/03/19	06:15	PR Newswire (US)	Eyetech to Present at the Eighth Annual Lehman Brothers Global Healthcare Conference	NASDAQ:EYET	Eyetech Pharmaceuticals (MM)